Advanced search
Publication Cover
Cancer Investigation Volume 41, 2023 - Issue 8
Submit an article Journal homepage
712
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Tumor Differentiation as a Prognostic Marker in Clinically Staged T1bN0 Esophageal Adenocarcinoma

Ofer Margalita Department of Oncology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel;b Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, IsraelCorrespondence[email protected]
View further author information
,
Einat Shacham-Shmuelia Department of Oncology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel;b Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, IsraelView further author information
,
Gal Straussa Department of Oncology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel;b Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, IsraelView further author information
,
Yu-Xiao Yangc Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA;d Department of Medicine, Division of Gastroenterology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USAView further author information
,
Yaacov R. Lawrencea Department of Oncology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel;b Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, Israel;e Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USAView further author information
,
Alon Ben Nunf Faculty of Medicine, Ben-Gurion University, Be’er-Sheva, Israel;g Assuta Medical Center, Tel-Aviv, IsraelView further author information
,
Idan Levyh Department of Gastroenterology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, IsraelView further author information
,
Kim A. Reissi Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USAView further author information
,
Talia Golana Department of Oncology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel;b Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, IsraelView further author information
,
Naama Halperna Department of Oncology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel;b Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, IsraelView further author information
,
Dan Aderkaa Department of Oncology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel;b Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, IsraelView further author information
,
Bruce Giantonioj Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USAView further author information
,
Ronac Mamtanic Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA;f Faculty of Medicine, Ben-Gurion University, Be’er-Sheva, IsraelView further author information
&
Ben Boursia Department of Oncology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel;b Faculty of Medicine, Tel-Aviv University, Ramat-Aviv, Tel-Aviv, Israel;c Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USAView further author information
 show all
Pages 734-738 | Received 29 Mar 2023, Accepted 02 Sep 2023, Published online: 18 Sep 2023

References

  • Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345(10):725–730. doi:10.1056/NEJMoa010187.
  • Smalley SR, Benedetti JK, Haller DG, Hundahl SA, Estes NC, Ajani JA, et al. Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol. 2012;30(19):2327–2333. doi:10.1200/JCO.2011.36.7136.
  • Puli SR, Reddy JB, Bechtold ML, Antillon D, Ibdah JA, Antillon MR. Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol. 2008;14(10):1479–1490. doi:10.3748/wjg.14.1479.
  • Wallace MB, Nietert PJ, Earle C, Krasna MJ, Hawes RH, Hoffman BJ, et al. An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy. Ann Thorac Surg. 2002;74(4):1026–1032. doi:10.1016/s0003-4975(02)03875-4.
  • Markar SR, Gronnier C, Pasquer A, Duhamel A, Beal H, Théreaux J, et al. Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study. Eur J Cancer. 2016;56:59–68. doi:10.1016/j.ejca.2015.11.024.
  • Mariette C, Dahan L, Mornex F, Maillard E, Thomas P-A, Meunier B, et al. Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901. J Clin Oncol. 2014;32(23):2416–2422. doi:10.1200/JCO.2013.53.6532.
  • Margalit O, Shacham-Shmueli E, Yang Y-X, Lawerence YR, Levy I, Reiss KA, et al. Prognostic implications of tumor differentiation in clinical T1N0 gastric adenocarcinoma. Oncologist. 2021;26(1):e111–e114. doi:10.1002/onco.13542.
  • Winchester DP, Stewart AK, Bura C, Jones RS. The National Cancer Data Base: a clinical surveillance and quality improvement tool. J Surg Oncol. 2004;85(1):1–3. doi:10.1002/jso.10320.
  • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8.
  • Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–619. doi:10.1016/0895-4356(92)90133-8.
  • Czito BG, Palta M, Willett CG. Results of the FFCD 9901 trial in early-stage esophageal carcinoma: is it really about neoadjuvant therapy? J Clin Oncol. 2014;32(23):2398–2400. doi:10.1200/JCO.2014.55.7231.
  • Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008;26(7):1086–1092. doi:10.1200/JCO.2007.12.9593.
  • van Hagen P, Hulshof MCCM, van Lanschot JJB, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BPL, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–2084. doi:10.1056/NEJMoa1112088.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.